Cargando…
Validation of an FFF-MALS Method to Characterize the Production and Functionalization of Outer-Membrane Vesicles for Conjugate Vaccines
[Image: see text] With the ongoing development of conjugate vaccines battling infectious diseases, there is a need for novel carriers. Although tetanus toxoid and CRM197 belong to the traditional carrier proteins, outer-membrane vesicles (OMVs) are an excellent alternative: in addition to their size...
Autores principales: | van der Put, Robert M. F., Spies, Arnoud, Metz, Bernard, Some, Daniel, Scherrers, Roger, Pieters, Roland, Danial, Maarten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453738/ https://www.ncbi.nlm.nih.gov/pubmed/36007249 http://dx.doi.org/10.1021/acs.analchem.2c01590 |
Ejemplares similares
-
Carriers and Antigens: New Developments in Glycoconjugate Vaccines
por: van der Put, Robert M.F., et al.
Publicado: (2023) -
Physicochemical characterization and study of molar mass of industrial gelatins by AsFlFFF-UV/MALS and chemometric approach
por: Duthen, Simon, et al.
Publicado: (2018) -
In vitro alternative for reactogenicity assessment of outer membrane vesicle based vaccines
por: Molenaar-de Backer, Marijke W. A., et al.
Publicado: (2023) -
Outer membrane vesicles as platform vaccine technology
por: van der Pol, Leo, et al.
Publicado: (2015) -
The Role of Virulence Proteins in Protection Conferred by Bordetella pertussis Outer Membrane Vesicle Vaccines
por: Raeven, René H. M., et al.
Publicado: (2020)